Filing Details

Accession Number:
0001127602-14-027606
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-09-11 16:39:30
Reporting Period:
2014-09-02
Filing Date:
2014-09-11
Accepted Time:
2014-09-11 16:39:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884731 Ariad Pharmaceuticals Inc ARIA Biological Products, (No Disgnostic Substances) (2836) 223106987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
932052 D M J Harvey Berger C/O Ariad Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge MA 02139
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-09-02 12,500 $6.22 1,726,786 No 4 P Indirect Ocean Capital Partners, Llc
Common Stock Acquisiton 2014-09-03 12,500 $6.31 1,739,286 No 4 P Indirect Ocean Capital Partners, Llc
Common Stock Acquisiton 2014-09-09 150,000 $5.23 1,294,277 No 4 M Direct
Common Stock Disposition 2014-09-09 124,613 $5.75 1,163,564 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Ocean Capital Partners, Llc
No 4 P Indirect Ocean Capital Partners, Llc
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2014-09-09 150,000 $0.00 150,000 $5.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2007-09-09 2014-09-09 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 246,054 Indirect Daughter
Common Stock 248,745 Indirect Daughter
Common Stock 245,251 Indirect Wife
Footnotes
  1. Shares were aquired pursuant to a 10b5-1 plan.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.14 to $6.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
  3. The reporting person is a managing member of this LLC.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.26 to $6.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
  5. Shares were acquired upon the exercise of outstanding stock options at $5.23 per share.
  6. Represents shares withheld to pay for the exercise cost related to the exercise of outstanding options and to satisfy withholding tax requirements.